About the initiative

The Medicare Benefits Schedule (MBS) is a list of health professional services that the Australian Government subsidises. MBS items provide patient benefits for a wide range of health services including consultations, diagnostic tests and operations.

Between 2015 and 2020, the MBS Review Taskforce looked at more than 5,700 MBS items to see if they needed to be amended, updated or removed. It identified services that were obsolete, outdated or potentially unsafe.

The taskforce also recommended adding new items where needed, along with broader structural changes to the MBS.   

Why it is important

This was the most thorough review of Medicare since it began in 1984. The review process is an important step towards safer, more modern care for all Australians.


This review aimed to improve the MBS by:

  • updating the MBS to reflect current medical practices and ensure patient safety
  • delivering greater consistency and clarity across different parts of the MBS
  • promoting better use of data and evidence to support MBS services.

Review process

Consultation with stakeholders was central to the MBS Review. The taskforce received feedback from thousands of stakeholders, which helped inform its final recommendations to the Government.

The process was as follows:

  • Taskforce established. The Government established the MBS Review Taskforce to address feedback from clinicians and the broader community that some services on the MBS did not reflect clinical best practice. The MBS Review Taskforce considered more than 5,700 items on the MBS. It looked at how the items could be aligned with contemporary clinical evidence and practice and improve health outcomes for all Australians.
  • Committees established. The taskforce set up discipline-specific clinical committees and working groups, which reviewed a defined range of existing MBS items. The Principles and Rules Committee reviewed the enforceable rules and regulations underpinning the MBS, to ensure they were up-to-date and supported contemporary clinical practice.
  • Public consulted. The committees released their reports with draft recommendations and invited stakeholder feedback. The recommendations did not represent the final position on items, but were subject to stakeholder and taskforce consideration.
  • Committees considered public feedback. The committees assessed the advice from public consultation and decided if any changes were needed to the recommendations. They then sent their recommendations to the MBS Review Taskforce.
  • Taskforce considered committee and public feedback. The taskforce considered committees’ recommendations as well as the information provided by the public to make sure that all the important concerns were addressed.
  • Taskforce delivered final recommendations to government. The taskforce delivered recommendations throughout the MBS Review process, and delivered their final report in December 2020. 
  • Taskforce developed ongoing system of review. This will make sure the MBS remains up-to-date.
  • Government progressively considers taskforce recommendations and implements changes as agreed. The end result of the process is a better MBS for all Australians.

Clinical committees

The taskforce established over 100 clinical committees and working groups to provide it with expert advice about each area of clinical practice that the MBS supports.

Clinical committees and their working groups examined MBS items in a particular clinical area, to align those items with modern clinical evidence and best practice. Over 700 clinicians, consumers and health system experts participated in these committees, providing detailed advice on how to improve the MBS.

Clinical committees consisted of a Chair who was a clinician practising in the area under review, and members including:

  • other clinicians
  • health system experts
  • general practitioners
  • consumers.

The committees sometimes set up working groups and reference groups to consider targeted clinical issues. Some working groups reported directly to the taskforce, and others through the clinical committee.

See the clinical committee reports.  

Primary Care process

Several groups reviewed Primary Care items:

  • General Practice Primary Care Clinical Committee (GPPCCC)
  • 6 Primary Care Reference Groups.

After public consultation, these groups submitted final reports to the MBS Review Taskforce in August 2019.

The taskforce noted that there was significant overlap across the 101 recommendations. It then assessed the recommendations individually and as part of theme groups to create a final overarching report. The section ‘Key themes’ within the final Primary Care report outlines this process.

Developing a consistent report meant that the taskforce’s Primary Care recommendations:

  • were consistent
  • did not fragment patient care
  • did not create unintended consequences.

You can read the taskforce reports on Primary Care, including its findings on each Primary Care Reference Group report.


The MBS Review Taskforce delivered its final report in December 2020. Between 2015 and 2020 it delivered over 60 detailed clinical reports containing more than 1,400 recommendations. See our collection of MBS Review Taskforce reports and recommendations.

MBS Review – Final taskforce reports, findings and recommendations

This collection contains all the final reports, findings and recommendations from the Medicare Benefits Schedule (MBS) Review Taskforce to the Australian Government.


The taskforce completed its work on 30 June 2020. It has sent almost 1,400 recommendations to the Australian Government for consideration.

The Government began responding to taskforce recommendations in 2016. Through Budget cycles it has progressively announced changes to the MBS arising from taskforce recommendations.  

As at July 2021, the Australian Government has:

  • agreed to 811 taskforce recommendations
  • implemented more than 580 recommendations, involving changes to over 3,000 MBS items.


The Government decides whether to adopt the recommendations. Once it supports a recommendation, work begins on implementing the resulting changes.

Implementation timing may vary due to complexity and impacts on stakeholders. We understand that many people want an immediate response and change. However, the taskforce’s recommendations are significant in number, scale and scope.

It can take 12 to 18 months to fully implement a change. Changes to MBS items require:

  • regulatory changes
  • mapping changes – advising practitioners, hospitals, insurers and other stakeholders
  • updating IT payment systems
  • updating MBS Online
  • advising stakeholders via webinars and fact sheets.

Implementation timeline


Recommendations implemented


Obsolete items



Ear, Nose and Throat

Diagnostic Imaging (bone density, low back)

Principles and Rules



Urgent After Hours GP

Gynaecology (pelvic mesh)

Thoracic Medicine

Diagnostic Imaging (knee imaging and 3D breast tomosynthesis)

Spinal Surgery

Renal Medicine

Dermatology, Allergy and Immunology



Ear, Nose and Throat (stroboscopy)

Anaesthesia (phase 1)

Diagnostic Imaging (pulmonary embolism and deep vein thrombosis)

Eating Disorders



Intensive Care and Emergency Management

Diagnostic Imaging (including breast imaging and nuclear)

Cardiac Imaging Services


Neurosurgery and Neurology

Blood Products



General Surgery

Orthopaedic Surgery

Cardiac Surgical Services

Vascular (varicose veins)*

General Practice and Primary Care* (new case conferencing items for allied health professionals who participate in case conferences that are organised by a patient's GP)



Pain Management*

Colorectal Surgery*

Plastic and Reconstructive Surgery*


Mental Health* (group therapy sessions and participation of family and carers in treatment)

  • * Announced in Budget 2021–22.

Ongoing consultation

We are establishing Implementation Liaison Groups (ILGs) for ongoing stakeholder consultation. As we work to implement recommendations, these groups help us to:

  • do it in a way that best meets patients’ safety and care needs
  • make sure there are no unintended consequences.

ILG members are generally professional organisations, practicing clinicians, and consumer representatives. For more information on ILGs, contact us.

News and updates

When the Government endorses implementation of a recommendation, we announce it through:


Medicare Benefits Schedule Review Taskforce contact

Contact us with questions about the Medicare Benefits Schedule (MBS) Review Taskforce.

MBSReviews [at] health.gov.au

View contact

Last updated: 
6 October 2021